Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France

por Caillon, Megane, Brethon, Benoit, van Beurden-Tan, Chrissy, Supiot, Romain, Le Mezo, Antoine, Chauny, Jean-Vannak, Majer, Istvan, Petit, Arnaud
Publicado 2023

A telemonitoring programme in patients with heart failure in France: a cost-utility analysis

por Caillon, Mégane, Sabatier, Rémi, Legallois, Damien, Courouve, Laurène, Donio, Valérie, Boudevin, Florence, de Chalus, Thibault, Hauchard, Karine, Belin, Annette, Milliez, Paul
Publicado 2022